Olsalazine 250 mg capsule (Dipentum): Supply issue
The supplier (Clinect) has advised PHARMAC that from February 2021 olsalazine 250 mg capsule (Dipentum) will be out of stock long term.
The stock shortage is caused by issues at the manufacturer level.
The olsalazine 500 mg tablet (Dipentum) presentation is funded and is available.
PHARMAC has received clinical advice that the olsalazine 500 mg tablet is a suitable funded alternative. It can be halved for patients requiring doses below 500 mg.
Who to contact
If you have any questions about this supply issue, contact Clinect firstname.lastname@example.org